Will 3 mg THC beverages be federally legal to sell on Nov 16, 2026?

- [2025-11-12] President Trump signed Public Law 119-37 (H.R. 5371), with Section 781 rewriting the federal statutory definition of "hemp" under 7 U.S.C. §1639o to a "total THC" standard (counting THCA and other cannabinoids) and a combined per-container cap, originally effective 365 days later. https://www.cornbreadhemp.com/blogs/learn/federal-hemp-ban-what-it-means-and-whats-happening-now - [2026-08-08] The Senate passed H.R. 6500 90-6 with language (later Section 2019) that would limit most Section 781 amendments' application until a later date. https://www.herb.agency/post/when-does-hemp-ban-take-effect - [2026-09-01] The House concurred in the Senate amendments to H.R. 6500 by a vote of 370-48. https://raleighdispensaries.com/blog/nc-hemp-law-update-2026 - [2026-09-02] President Trump signed H.R. 6500 into law as Public Law 119-103; its Section 2019 creates a two-date Section 781 timeline. https://raleighdispensaries.com/blog/nc-hemp-law-update-2026 - [2026-09-02] Per Section 2019, until December 11, 2026 the Section 781 amendments "shall only apply" to the two subclauses (Section 297A(1)(C)(ii)(I) and (1)(C)(iv)(I)) covering cannabinoids "not capable of being naturally produced by a Cannabis sativa L. plant" — i.e., only non-natural/synthetic cannabinoid provisions take effect Nov 12, 2026. https://www.cbdinstock.com/federal-hemp-deadlines-november-december-2026/ - [2026-09-02] The broader changes — the 0.3% total-THC/THCA counting standard and the 0.4 mg combined-total per-container cap that would exclude a typical THC beverage from "hemp" — are deferred and do not begin applying until December 11, 2026 absent further Congressional action. https://www.nextlevelleaf.com/blog/section-781-hemp-deadline-tracker/ - [2026-10-07] Per a legal tracker reviewed October 7, 2026, "for a conventional hemp-derived delta-9 beverage, the finished-product 0.4 milligram-per-container clause is not among the provisions that Section 2019 makes applicable before December 11." https://www.nextlevelleaf.com/blog/section-781-hemp-deadline-tracker/ - [2026-09-28] CRS report IF13136 (updated Sept 28, 2026) notes FDA still had not published the required Section 781 cannabinoid lists/"container" definition as of that date. https://www.nextlevelleaf.com/blog/section-781-hemp-deadline-tracker/ - [2026-10-07] Several longer-term bills remain pending in Congress without floor votes: H.R. 10079 (Beverage Regulatory Parity Act, 5 mg/serving beverage carve-out), H.R. 9830 (Lawful Hemp Protection Act, repeal/replace Section 781), and H.R. 7024 (three-year delay to Nov. 2028) — none enacted. https://www.nextlevelleaf.com/blog/section-781-hemp-deadline-tracker/ - [2026-09-24] The Senate Agriculture Committee reported a 2026 Farm Bill (S. 5526); a search of its reported text found no mention of "hemp," "Cannabis," or "1639o," so it is not currently a Section 781 vehicle. https://www.nextlevelleaf.com/blog/section-781-hemp-deadline-tracker/ - [2026-04-29] The U.S. House previously passed its own 2026 Farm Bill (H.R. 7567) without any language delaying the Section 781 hemp deadline. https://raleighdispensaries.com/blog/nc-hemp-law-update-2026 - [2026-09-12] Multiple state-level trackers (e.g., North Carolina) now describe December 11, 2026, rather than November 12, as the date the "federal ban" with the 0.4mg cap "takes full effect." https://raleighdispensaries.com/blog/nc-hemp-law-update-2026 BOTTOM LINE: The market's resolution date (end of Nov 16, 2026) falls after the narrow Nov 12 provision (targeting only non-naturally-producible cannabinoids) but before the broader Dec 11, 2026 provisions (the total-THC/THCA standard and the 0.4mg-per-container cap) that would otherwise exclude a naturally-derived 3mg delta-9 beverage from the federal hemp definition; because Congress's Sept 2 extension (P.L. 119-103) specifically delays those disqualifying provisions past Nov 16, the described product appears to remain statutorily within the hemp definition (not a controlled substance) on that date absent a further legal change. NOT FOUND: No confirmation of any enacted law, FDA cannabinoid-list publication, or federal court injunction issued since Sept 2, 2026 that would change this Nov 16 status before close; no evidence the Nov 16, 2026 resolution date itself is referenced in any official tracker (all trackers use Nov 12/Dec 11 framing); could not verify the current status of a potential government shutdown or appropriations lapse around the Dec 11 funding deadline affecting enforcement posture.

- [2026-09-02] President Trump signed H.R. 6500 (P.L. 119-103), which, per Section 2019, delays most of Section 781's hemp-redefinition provisions (the total-THC standard and the 0.4 mg per-container cap) from Nov 12 to Dec 11, 2026, leaving only the "cannabinoids not naturally produced by the plant" exclusion to take effect Nov 12. On September 2, 2026, President Donald Trump signed a short-term government funding bill (H.R. 6500) that pushes back the scheduled federal restrictions on hemp-derived THC products from November 12 to December 11, 2026. (https://foleyhoag.com/news-and-insights/blogs/cannabis-and-the-law/2026/september/a-temporary-reprieve-for-hemp-thc-products%E2%80%A6-but-what-now/) - [2026-09-19] This is already the second time Congress has pushed the hemp-cliff date via a must-pass funding vehicle (first the original 2025 shutdown-ending CR created the cliff, then the Sept 2026 CR delayed it), establishing a reference-class pattern of last-minute riders altering hemp deadlines; a tracker reports the White House said there would be "no second extension," but that pledge was never put into statute and the official who made it left the administration (https://www.ediblerank.com/legal/hemp-ban-2026). - [2026-10-08] The reference class of comparable legislative "cliffs" in this saga shows repeated near-miss delays rather than clean enactment of restrictions: the Senate passed the delay 90-6 and the House passed it 370-48 before Trump's signature, indicating broad bipartisan appetite for kicking the can, a pattern consistent with past farm-bill/CR hemp provisions being softened or delayed at the last minute (https://www.learnbrands.com/post/hemp-thc-beverage-ban-november-2026). - [2026-10-08] Independent forecasting model "Octagon" estimated the probability of 3 mg THC beverages qualifying as hemp at 53.3% as of late August 2026 for the Nov 13, Dec 10, and Mar 13 horizons, while the associated prediction market (Kalshi) had moved from 25% to 76-78% over the same window, showing a large and growing model-market divergence The market prices this outcome at 78.0%, diverging significantly from the model's 53.3%. Our model puts On Dec 10, 2026 at 53% (market 76%). (https://www.octagonai.co/markets/politics/congress/will-3-mg-thc-beverages-qualify-as-hemp-under-federal-law) - [2026-08-23 to 08-27] Historically, within this saga, market-moving events have consistently been legislative actions that ease or delay restrictions (never actions that accelerate or harden the ban): a spike followed introduction of the bipartisan Beverage Regulatory Parity Act, and another followed the Senate Appropriations Committee's draft CR delaying the restrictions A later 9.0 point increase on August 27 followed the Senate Appropriations Committee's introduction of a continuing resolution. Both legislative actions directly counter the tighter rules enacted in November 2025 (https://www.octagonai.co/markets/politics/congress/will-3-mg-thc-beverages-qualify-as-hemp-under-federal-law). - [2025-11-20 to 2026-08] Four separate standalone bills (Mace's American Hemp Protection Act, the Barr/Craig Lawful Hemp Protection Act, Wyden/Merkley's Cannabinoid Safety and Regulation Act, Paul/Klobuchar/Ernst's Hemp Safety Enforcement Act) and the Beverage Regulatory Parity Act have been introduced to repeal, delay, or carve out exceptions to Section 781, but as of the most recent tracking none had received a committee hearing or markup, reflecting the base-rate difficulty of passing standalone cannabis-related legislation through a divided Congress Representatives Jim Baird and Betty McCollum signed on August 31, bringing it to seven cosponsors, and Barr's office says it has White House approval. It still faces long odds in a divided Congress and has not had a hearing or markup. - [2025-11-12] For base-rate context on the underlying policy itself: the original hemp "loophole" that enabled THC beverages was unintentionally created by the 2018 Farm Bill's dry-weight definition, and it took Congress roughly seven years (and only via an unrelated must-pass appropriations/shutdown-ending vehicle) to close it, illustrating that major hemp-policy changes in this domain have historically moved only via must-pass vehicles, not standalone bills A coalition of 39 state attorneys general submitted a letter urging Congress to close the gap... Substantially similar legislative language had been considered and rejected during the 118th Congress and during the initial FY2026 appropriations process. The provision's inclusion in the government-reopening package, a must-pass vehicle, foreclosed standalone debate. - [2026-09-16] The Senate Agriculture Committee advanced a farm bill 12-11 that contains no hemp language, and the House farm bill (passed April 30, 2026, 224-200) also kept the ban intact, showing that the "regular order" legislative track has so far failed to produce a fix, pushing resolution back toward funding-bill riders as the base-rate mechanism for change (https://www.ediblerank.com/legal/hemp-ban-2026). - [2026-10-08] Courts have so far granted only narrow, party-specific relief (e.g., Ohio federal preliminary injunctions covering 10 then 14 named companies, later partly stayed by the Sixth Circuit; Texas state injunctions won and then lost on appeal), consistent with the historical base rate that hemp-industry litigation produces fragmented, temporary, non-nationwide relief rather than broad or final rulings (https://www.ediblerank.com/legal/hemp-ban-2026). BOTTOM LINE: The reference class here is a young (under 1 year old), fast-moving legislative fight with no exact historical precedent, but the closest analog—recurring must-pass-vehicle riders repeatedly delaying (not repealing) the hemp cliff, standalone bills stalling in committee, and courts granting only narrow relief—shows a pattern of serial short delays rather than permanent resolution; independent model estimates (~53%) are notably more conservative than the fast-rising market price, suggesting outside forecasters see more uncertainty than the market currently prices in. NOT FOUND: No single authoritative historical base-rate dataset specifically for "federal cannabinoid cliff dates delayed/reversed by Congress" exists (this is a novel policy area); no confirmed Kalshi-independent polling or betting-market history predating the current contract; no evidence of any federal court order with nationwide, product-class-wide effect (condition (b) in the rules) as of the search date.

YES means: as of the end of Nov 16, 2026, the described product (a sealed 12 fl oz container with exactly 3 mg naturally-produced delta-9 THC, no THCA, no other cannabinoids) is treated under federal statutory/regulatory law as not a Schedule I controlled substance — i.e., it still qualifies as "hemp" under 7 U.S.C. §1639o as currently in effect, satisfying condition (a) of the resolution criteria. - [2026-09-02] President Trump signed H.R. 6500 (P.L. 119-103); Section 2019 confines the Section 781 hemp-redefinition amendments to only the subclauses covering cannabinoids "not capable of being naturally produced by a Cannabis sativa L. plant" until December 11, 2026, leaving the broader total-THC standard and 0.4 mg/container cap dormant until then. https://www.rcrcnet.org/general/u-s-senate-funding-bill-would-temporarily-narrow-hemp-thc-ban/ - [2026-09-28] CRS Report IF13136 (updated Sept 28, 2026) confirms that the change to the definition—originally scheduled to go into effect on November 12, 2026—has had the effective date for portions of the definition of hemp delayed until December 11, 2026 following passage of P.L. 119-103 , directly spanning the Nov 16 resolution date. - [2026-10-07] A legal tracker dated the day before our colleagues' report states plainly that for a conventional hemp-derived delta-9 beverage, the 0.4 mg per-container clause and total-THC counting (which would disqualify such a beverage) are listed as taking effect only "from Dec 11, 2026 (law unchanged)," while "through Dec 10, 2026" delta-9 beverages remain "Hemp if ≤0.3% delta-9 by dry weight." A 3 mg delta-9 beverage in a 355 mL (12 oz) container is far below the 0.3%-by-dry-weight delta-9 threshold, so it squarely remains "hemp" on Nov 16. - [2026-10-05] Reuters-syndicated reporting (Quartz, Oct 5, 2026) corroborates that the ban's original November start date was delayed by a month, buying Congress additional time to work toward a permanent fix , with the operative new cliff being December, after the Nov 16 resolution date. - [2026-10-03] The Washington Times (Oct 3, 2026) confirms the short-term government-funding bill signed by President Trump last month delayed the effective date of the "hemp THC ban" from Nov. 12 to Dec. 11 , giving Congress more time before any disqualifying cap applies. - [2026-09-19] Foley Hoag's client alert states the reprieve applies broadly: on September 2, 2026, President Trump signed H.R. 6500 that pushes back the scheduled federal restrictions on hemp-derived THC products from November 12 to December 11, 2026 ; only synthetic/non-naturally-producible cannabinoids are excluded immediately, which does not describe this product since it contains "exactly 3 mg" naturally-produced delta-9 and nothing else. - [2026-09-28] CRS IF13136 also flags that FDA has not yet issued the implementing lists of "naturally occurring" vs. other cannabinoids required by Section 781, meaning there is no federal regulatory action in effect by Nov 16 that could reclassify a pure, naturally-derived delta-9 beverage as containing a "non-natural" cannabinoid — the only category subject to the earlier Nov 12 cutoff. - [2026-10-08] The bill that created the Nov 12→Dec 11 delay passed with overwhelming bipartisan margins (Senate 90-6, House 370-48) per colleagues' prior research, and no subsequent repeal, acceleration, or reversal of that delay has been found in any search through Oct 9, 2026 — the delay remains the controlling, enacted statutory text covering Nov 16. - [2026-10-03] NPR's reporting frames the real battleground as the "year-end countdown" to Dec 11, not mid-November, reinforcing that a federal ban on hemp-derived THC drinks and gummies is set to take effect at year's end rather than before Nov 16. - Mechanism to YES: no further congressional or executive action is required between now and Nov 16 — condition (a) is already satisfied by law currently in effect (P.L. 119-103/Section 2019), since the disqualifying 0.4 mg cap and total-THC/THCA standard are statutorily inert until Dec 11, 2026, a date after the market's resolution point. BOTTOM LINE: On the literal statutory text in force today, a pure 3 mg natural delta-9, zero-THCA, zero-other-cannabinoid 12 oz beverage falls outside any disqualifying Section 781 provision until December 11, 2026, meaning it is lawful "hemp" (not a Schedule I substance) on November 16, 2026 under condition (a) — the strongest and most direct path to YES, requiring no new legislation, court order, or agency action, only that the already-enacted Dec 11 delay (P.L. 119-103) remain unaltered through the resolution date. NOT FOUND: No evidence of any new federal statute, regulation, or nationwide court order enacted after Sept 2, 2026 that would move the 0.4 mg/total-THC cutoff earlier than Dec 11 or otherwise disqualify a pure natural delta-9 product before Nov 16, 2026; no FDA publication (as of Oct 7-9, 2026 trackers) of the Section 781 cannabinoid/container lists that could affect classification before that date.

YES means: as of the end of Nov 16, 2026, a 12-fl-oz hemp beverage containing exactly 3 mg of natural, plant-derived delta-9 THC (and nothing else) is treated under federal statute/regulation as not a Schedule I controlled substance (or is independently rescued by a nationwide court order, a funding-prohibition statute, or express federal authorization). The strongest NO case argues this chain is more fragile and contestable than the current Sept-2026 delay suggests, leaving real residual risk of a NO. - [2026-09-02] The Sept 2 delay (P.L. 119-103) was adopted only after Sen. Ted Budd's floor amendment to strip the delay and keep the Nov 12 ban on schedule was tabled by a mere 61-32 vote, with 21 Republicans plus 11 Democrats voting to kill the delay — showing a large, persistent bloc (roughly a third of the Senate) actively opposed to the carve-out the YES case depends on. https://hightimes.com/analysis/hemp-ban-explained-senate-delay-december-11/ - [2026-09-01] In the House, 19 Republicans and 29 Democrats voted against the same delay (370-48), confirming bipartisan opposition exists in both chambers that could resurface in any new legislative vehicle before Nov 16. https://thehill.com/policy/healthcare/6064552-hemp-ban-delayed-house-funding-bill/ - [2026-08-04] A coalition of 35 state attorneys general (not the 39 cited for the original 2025 provision) formally urged Congress to "reject any effort to delay, repeal, suspend, or weaken" the hemp redefinition, and Indiana AG Todd Rokita publicly pressed Congress to "reject the delay, keep your promise and let the law take effect" — an organized push that could still find a legislative vehicle before Nov 16. https://thehill.com/policy/healthcare/6009069-senate-funding-bill-seeks-hemp-thc-ban-delay/ - [2026-08-06] The White House itself has said the September 30-day delay "would be the last extension it will support," signaling no further Executive accommodation if Congress tries to amend the Dec 11 date again — a stance that, if anything, raises the odds of brinkmanship rather than a clean further concession before the contract's Nov 16 deadline. https://www.hemplawgroup.com/news/federal-hemp-ban-2026-where-things-stand - [2026-09-28] CRS report IF13136 confirms FDA still had not published the statutorily required cannabinoid lists or the added "container" definition as of that date — the term "container" is also central to this contract's own definition of the product, so the absence of binding federal guidance leaves genuine interpretive uncertainty about whether the specific product described is unambiguously treated as lawful under "federal statutes and regulations in legal effect," rather than merely not-yet-restricted by default. https://www.hemplawgroup.com/news/federal-hemp-ban-2026-where-things-stand - [2026-09-03] FDA separately missed its original February 10, 2026 statutory deadline to publish these same cannabinoid/container lists, a seven-month-plus lapse that shows the agency's implementation of Section 781 is behind schedule in ways that could still generate rushed guidance or rulemaking before Nov 16 with unpredictable effect on the product's classification. https://www.hemplawgroup.com/news/federal-hemp-ban-2026-where-things-stand - [2026-10-05] No federal court order of nationwide, product-class-wide scope exists; relief so far has been limited to a handful of named Ohio companies (later partly stayed by the Sixth Circuit) and since-reversed Texas state injunctions, meaning condition (b) cannot rescue a YES outcome if the Section 2019 delay were narrowed or reversed before Nov 16. https://www.hytiva.com/news/congress-delays-federal-hemp-thc-ban-to-december-11-as-industry-presses-for-rules - [2026-09-03] None of the standalone fixes that could trigger condition (d) — the Beverage Regulatory Parity Act (H.R. 10079), the Lawful Hemp Protection Act (H.R. 9830), or the Hemp Planting Predictability Act (H.R. 7024/S. 3686) — had cleared committee as of early September, and the Senate Agriculture Committee's farm-bill markup separately failed 10-11 on an unrelated food-assistance dispute, leaving no active "express authorization" vehicle on track to pass before Nov 16. https://www.hemplawgroup.com/news/federal-hemp-ban-2026-where-things-stand - [2026-10-05] Government funding itself expires Dec 11, 2026, the same date set for the broader hemp restrictions, meaning Congress must reopen the underlying appropriations vehicle in the lame-duck period after the Nov 3 midterms — the same type of must-pass bill that twice already became the venue for hemp-date fights, creating a plausible (if not yet realized) channel for a rider to move the effective date earlier before the contract's Nov 16 close. https://perspectives.acct.org/stories/congress-passes-extension-through-december-11 - [2026-10-07] Independent payment-processor action (Square directing merchants to remove hemp/CBD products by Oct 15, 2026) shows the product is already facing real commercial disruption ahead of any federal deadline, illustrating that "legal to sell" in practice is contested even where federal statute has not yet changed, a factor that could color how ambiguously the resolution desk treats the current legal baseline. https://www.hemplawgroup.com/news/federal-hemp-ban-2026-where-things-stand BOTTOM LINE: The NO case does not rest on a currently-enacted rule that bans the product by Nov 16 — it rests on the fact that the only path to YES (condition (a)) depends entirely on an unreversed, narrowly-passed 30-day statutory carve-out, layered on top of undefined FDA terms, with an organized bipartisan-AG coalition and a real Senate/House opposition bloc still pushing to accelerate restrictions via the same kind of must-pass vehicle that produced two prior deadline changes. NOT FOUND: No evidence of any introduced or pending bill or amendment that would specifically move the Dec 11 (or Nov 12 synthetic-only) date earlier than Nov 16, 2026; no confirmation of any FDA or DEA rule, guidance, or enforcement action issued since late September 2026 that would alter the product's classification before Nov 16; no official statement addressing the Nov 16, 2026 date specifically (all trackers reference only Nov 12/Dec 11).